We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Recipharm Monts Secures Regulatory Approval from ANSM to Fill Biotech Products
News

Recipharm Monts Secures Regulatory Approval from ANSM to Fill Biotech Products

Recipharm Monts Secures Regulatory Approval from ANSM to Fill Biotech Products
News

Recipharm Monts Secures Regulatory Approval from ANSM to Fill Biotech Products

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Recipharm Monts Secures Regulatory Approval from ANSM to Fill Biotech Products"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Recipharm Monts has announced that it has secured authorization from the French health authorities (ANSM) to fill biotech products. Consequently, Recipharm is able to expand and diversify its combined offering.

The Monts site, which employs 200 personnel, comprises three filling lines. Two large capacity lines are used for glass vials for injection and a third one is an aseptic line that fills cartridges.

The timing of the new authorization coincides with the site installing a new, highly flexible vials line with multiple formats designed to handle smaller capacity orders.

The first production on this line, designed to fill both clinical and small commercial batches, will be readily available to the life science and pharmaceuticals market from mid 2013 onwards.

Michel Saudemon, General Manager at Recipharm Monts, commented: “We are delighted to have the opportunity to expand our sterile product manufacturing services with the authorized capability to fill biotech products.”

He added: “This regulatory approval, coming at a time when we have already set in place a programme of strategic expansion at the Monts site with the installation of a new service line, will serve to increase the range of sterile product manufacturing services that we can offer to the markets.”

Advertisement